The collaboration aims to deliver real-time image processing, robotic control and cloud-enabled intelligence in a unified architecture.
Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech customers.
Transaction Expected to Help Hologic Strengthen its Leadership in Women’s Health and Accelerate Growth
Asset acquisition expected to expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.
Boston Sci acquisition expected to expand the neuromodulation offerings for people living with chronic pain.
GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials.
Originally CE marked in 2021 for limited to high-risk patients only, .Abbott has now received CE mark approval for its Navitor transcatheter aortic valve replacement (TAVR) system to treat low- and intermediate-risk patients with symptomatic, severe aortic stenosis.
Company says the system empowers clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move.
The Globe System, according to the company, achieves highly durable lesions and an excellent safety profile, together with integrated high-density mapping and true single-shot PVI for treatment of atrial fibrillation.
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension.
